{"schema_version":"1","generated_at":"2026-11-01T01:08:06.801Z","data_as_of":null,"url":"https://www.findmykol.com/kol/pablo-mora","json_url":"https://www.findmykol.com/kol/pablo-mora/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"pablo-mora","name":"Pablo Mora","credential":"MD","specialty":"Endocrinology, Diabetes & Metabolism","specialty_raw":"Endocrinology, Diabetes & Metabolism","therapeutic_area":"Endocrinology/Metabolic","therapeutic_areas":["Endocrinology/Metabolic"],"city":"Plano","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1306836168","openalex":"A5107311130"},"summary":"Pablo Mora is an Endocrinology/Metabolic physician. OpenAlex indexes 24 publications with 253 citations (h-index 9).","overview":null,"focus":{"indications":[],"research_topics":["Endocrinology/Metabolic"]},"scholarship":{"works_count":24,"cited_by_count":253,"h_index":9,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":42,"program_years":{"first":2021,"last":null},"rows_total":95,"shown":3,"withheld":92,"rows":[{"payer":"Insulet Corporation","program_year":2025,"amount_usd":103172.97,"payment_count":191,"source_url":"https://openpaymentsdata.cms.gov/search?query=1306836168"},{"payer":"Novo Nordisk Inc","program_year":2025,"amount_usd":66415.88,"payment_count":80,"source_url":"https://openpaymentsdata.cms.gov/search?query=1306836168"},{"payer":"Dexcom, Inc.","program_year":2025,"amount_usd":61650.69,"payment_count":87,"source_url":"https://openpaymentsdata.cms.gov/search?query=1306836168"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1306836168","source":"payments"},"publications":{"total":23,"shown":5,"withheld":18,"matched_by":"OpenAlex author record","recent":[{"title":"1730-P: Zenagamtide (Amycretin), a Novel Unimolecular GLP-1 and Amylin Receptor Agonist: Phase 2b Results in T2D","year":2026,"journal":"Diabetes","source_url":"https://doi.org/10.2337/db26-1730-p","status":"verified"},{"title":"1866-P: MiniMed 780G Advanced Hybrid Closed-Loop (AHCL) Glycemic Benefits Are Observed across a Range of C-Peptide Levels in People with Type 2 Diabetes (PWT2D)","year":2026,"journal":"Diabetes","source_url":"https://doi.org/10.2337/db26-1866-p","status":"verified"},{"title":"2887-LB: Real-World Glycemic Outcomes Using the Omnipod Discover Data Management System","year":2026,"journal":"Diabetes","source_url":"https://doi.org/10.2337/db26-2887-lb","status":"verified"},{"title":"2010-LB: Safety and Glycemic Outcomes during MiniMed 780G System Use with the Disposable, All-in-One, Simplera Sync Sensor in People with Type 2 Diabetes (PwT2D)","year":2025,"journal":"Diabetes","source_url":"https://doi.org/10.2337/db25-2010-lb","status":"verified"},{"title":"Efficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device in type 2 diabetes","year":2020,"journal":"BMJ Open Diabetes Research & Care","source_url":"https://doi.org/10.1136/bmjdrc-2020-001832","status":"verified"}],"source":"works"},"contact":{"address_1":"4100 W 15TH ST STE 202","city":"Plano","state":"TX","zip":"750935801","phone":"972-943-5914","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1306836168","source":"identity"},"similar":[{"name":"Yousef Saleh Khader","slug":"yousef-khader","institution":"Jordan University of Science and Technology","url":"https://www.findmykol.com/kol/yousef-khader","json_url":"https://www.findmykol.com/kol/yousef-khader/profile.json"},{"name":"Jens Juul Holst","slug":"jens-holst","institution":"University of Copenhagen","url":"https://www.findmykol.com/kol/jens-holst","json_url":"https://www.findmykol.com/kol/jens-holst/profile.json"},{"name":"Victor Montori","slug":"victor-montori","institution":"Mayo Clinic","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/victor-montori","json_url":"https://www.findmykol.com/kol/victor-montori/profile.json"},{"name":"Christos Mantzoros","slug":"christos-mantzoros","institution":"Harvard Medical School","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/christos-mantzoros","json_url":"https://www.findmykol.com/kol/christos-mantzoros/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":92,"publications":18}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-12-29","provider_certified":"2025-12-29","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}